Spots Global Cancer Trial Database for Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging
Official Title: Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging: the MDS (Melanoma Detecting System)
Study ID: NCT02056522
Conditions
Interventions
Study Description
Brief Summary: The use of MDS to access the presence of melanoma in the skin.
Detailed Description: A topical agent is applied to suspicious skin lesions and imaged. The images are analyzed to provide a score that correlates with the probability for the presence of melanoma in the lesion.
Keywords
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Clalit Health Services, Kiryat Bialik, , Israel
Ziv Medical Center, Zefat, , Israel
Contact Details
Name: Shokrey Kassis, MA
Affiliation: Head of Plastic Surgery
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
